Insulet’s Omnipod is winning more diabetes patients, but keeping that momentum may depend on doctors, insurers, and health systems changing how they prescribe and pay for it. Big spending on new products and factory expansion could set up the next leg of growth—or expose costly execution slip-ups that slow progress.Read more
Insulet’s tubeless insulin pump is gaining traction as more people want app-connected, wearable diabetes care and insurers make it easier to get. The big question is whether this growth holds up as rivals innovate and the company stays heavily tied to one core product.Read more
Insulet’s tubeless Omnipod insulin pods could reach many more people as diabetes care shifts toward easier, more automated treatment—especially among adults with type two diabetes who are still early in adoption. The upside depends on the company keeping insurance access strong and scaling new factories smoothly, because setbacks in coverage, demand, or production could slow growth.Read more
No trending discussion available.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
